Proven treat - HRW

2
DRUG CONTROL AND ACCESS TO CONTROLLED MEDICINES: A GLOBAL VIEW ACCESS TO CONTROLLED MEDICINES AND THE UN DRUG CONVENTIONS The 1961 Single Convention on Narcotic Drugs obliges states to make “adequate provision… to ensure the availability of narcotic drugs” which continue to be “indispensable for the relief of pain and suffering.” The International Narcotics Control Board (INCB) has stated that the Single Convention “establishes a dual drug control obligation: to ensure adequate availability of narcotic drugs for medical and scientific purposes, while at the same time preventing the illicit production of, and trafficking in and use of such drugs.” Yet, the President of the INCB observed in July 2009 that access to controlled medicines is “virtually non-existent in over 150 countries.” Ensuring the availability of essential medicines like morphine, methadone and buprenorphine is a core obligation of governments under the right to the highest attainable standard of health. Drug control regulations that restrict the adequate availability of these medications violate that right. Denial of strong opioids to patients in severe pain can also constitute cruel, inhuman or degrading treatment. REGULATORY BARRIERS TO MEDICAL ACCESS TO CONTROLLED DRUGS Access to controlled medicines must be regulated to prevent their misuse. The 1961 Single Convention establishes three basic requirements for such regulations: Controlled medicines may be dispensed only pursuant to a prescription; A license must be required to manufacture, trade or distribute them, and Appropriate records must be kept. 1 Yet, many countries have enacted regulations that go well beyond what is required by the Single Convention and that impede availability of controlled medications. INCB has repeatedly called on countries to review their drug control regulations to assess whether they unnecessarily impede access to controlled medicines. 2 PRESCRIPTION PROCEDURES SPECIAL PRESCRIPTION FORMS Many countries, like Turkey, require use of a special prescription for controlled medicines. WHO has observed that special multiple-copy prescription requirements “typically reduce prescribing of covered drugs by 50 percent or more.” The requirement to use special prescription forms can be particularly burdensome if doctors have to apply to receive the forms, as in Morocco and Germany, or have to pay for them, as in the Philippines, Denmark, Albania and Estonia. Problems accessing enough special prescription forms have been reported in Turkey, El Salvador and Ukraine. PRESCRIPTION LIMITATIONS Many countries, like Morocco, limit the number of days a prescription for controlled medicines can cover. WHO recommends “decisions concerning…the amount of the prescription and the duration of therapy are best made by medical professionals on the basis of the individual need of the patient, not by regulation.” 3 Extreme time limits include Ukraine (1 day), Belarus (3 days), Greece, Lithuania and Russia (5 days). In many other countries, an opioid prescription may be valid for as many as 90 days or there is no limitation at all. 4 RIGHT TO PRESCRIBE LIMITED TO CERTAIN SPECIALISTS Like Montenegro, some countries limit the right to prescribe opioids to doctors practicing in certain specialties, commonly oncology, pain management or anesthesiology. Such restrictions significantly limit patients’ access to opioid medicines. The WHO recommends that “physicians, nurses and pharmacists should be legally empowered to prescribe, dispense and administer opioids to patients in accordance with local needs.” 5 Countries with similar restrictions include, among others, Egypt and Ukraine. 6 LICENSING REQUIREMENTS SPECIAL LICENSES FOR DOCTORS In many countries, like Greece, doctors need a special license or registration to prescribe controlled medicines. While in some countries the process for obtaining a license is simple, in others obtaining it requires considerable paperwork or even invasive screening of the doctor. For example, the Philippines requires doctors applying for a license to submit to blood tests. As a result of excessively complex licensing procedures in some countries, including Morocco and the Philippines, very few doctors obtain them. 7 LICENSES FOR PHARMACIES, HOSPITALS AND HOSPICES The UN drug conventions require that states create a system to license healthcare institutions that handle opioid medications. Some countries arbitrarily exclude certain healthcare facilities from eligibility for a license *Except where otherwise noted, all information is from Human Rights Watch interviews or correspondence with healthcare professionals in the countries mentioned. These examples are illustrative of regulations that promote or impede access to controlled medicines and do not fully reflect the regulatory environment in the countries mentioned. These examples are not intended to suggest that practices in the countries mentioned are better or worse than those in countries not mentioned. Non-regulatory barriers also contribute to the unavailability of controlled medicines, particularly inadequate training for healthcare workers in their use. Additional sources of information on reverse: Jordan: Jan Stjernswärd et al., “Jordan Palliative Care Initiative: A WHO Demonstration Project”, Journal of Pain and Symptom Management, vol. 33 no. 5, May 2007, 631; Rwanda: International Narcotics Control Board, Narcotic Drugs: Estimated World Requirements for 2009 – Statistics for 2007, E/F/S.09.XI.02 (New York: United Nations, 2009), p. 241; K. M. Foley, “Pain Syndromes in Patients with Cancer,” in K. M. Foley, J. J. Bonica and V. Ventafridda, eds., Advances in Pain Research and Therapy, (New York: Raven Press, 1979), 981_994; UNAIDS, “Rwanda: Country Situation”, July 2008, http://data.unaids.org/pub/FactSheet/2008/sa08_rwa_en.pdf (accessed February 9, 2010); Singapore: Central Narcotics Bureau, Annual Bulletin, 2007. 1 Single Convention on Narcotic Drugs, 1961, adopted March 30, 1961, 520 U.N.T.S. 151, entered into force December 13, 1964, preamble. 2 International Narcotics Control Board, “Availability of Opiates for Medical Needs: Report of the International Narcotics Control Board for 1995,” http://www.incb.org/pdf/e/ar/1995/suppl1en.pdf (accessed February 10, 2010), p. 1. 3 UN Economic and Social Council, “Statement by Professor Sevil Atasoy, President of the International Narcotics Control Board,” July 30, 2009, http://www.incb.org/documents/President_ statements_09/2009_ECOSOC_Substantive_Session_published.pdf (accessed February 10, 2010), p. 2. 4 UN Committee on Economic, Social and Cultural Rights, “Substantive Issues Arising in the Implementation of the International Covenant on Economic, Social and Cultural Rights,” General Comment No. 14, The Right to the Highest Attainable Standard of Health, E/C.12/2000/4 (2000), http://www.unhchr.ch/tbs/doc.nsf/ (symbol)/E.C.12.2000.4.En (accessed February 9, 2010), para. 43. 5 Human Rights Council, Report of the Special Rapporteur on Torture and Other Cruel, Inhuman or Degrading Treatment or Punishment, Manfred Nowak, “Promotion and Protection of All Human Rights, Civil Political, Economic, Social and Cultural Rights, including the Right to Development,” A/HRC/10/44, January 14, 2009, para. 72. 6 International Narcotics Control Board, Report of the International Narcotics Control Board for 2008, E.09.XI.1 (New York: United Nations, 2009), p. 118. 7 WHO, Cancer pain relief: with a guide to opioid availability, 2nd ed., (Geneva: WHO, 1996). 8 N.I. Cherney et.al, “Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: a report from the ESMO/EAPC Opioid Policy Initiative”, Annals of Oncology, forthcoming, February 2010. 9 Evan Anderson et al., “Closing the Gap: Case Studies of Opioid Access Reform in China, India, Romania & Vietnam” (Centers for Law and Public Health: A Collaborative at the Johns Hopkins and Georgetown Universities, 2008). 10 WHO, UNODC, UNAIDS, Position Paper: Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention, (Geneva: World Health Organization, 2004). 11 Catherine Cook and Natalya Kanaef, Global State of Harm Reduction 2008: Mapping the response to drug-related HIV and Hepatitis C epidemics (London: International Harm Reduction Association, 2008). 12 Daniela Mosoiu, et al., “Romania: Changing the Regulatory Environment,” Journal of Pain and Symptom Management, vol. 33 no. 5, May 2007, 610. 13 International Narcotics Control Board, Report of the International Narcotics Control Board for 2004, E.05.XI.3 (New York: United Nations, 2005), para. 196. or have unnecessarily burdensome licensing procedures that deter pharmacies and medical institutions from stocking controlled medicines, and divert healthcare workers’ time from providing medical care. The licensing system in most of India’s states, where healthcare providers must obtain five different licenses from several government agencies, is a prime example. To its credit, the Indian government has recommended partial reform to improve patient access to morphine. Today, 14 states have adopted a new, simple system for morphine that involves obtaining one license from one government agency. In China, hospitals are categorized according to their size, and only larger hospitals are authorized to handle opioids. As a result, people living outside of large cities have to travel much further to obtain opioid medicines than they would if they were available in all hospitals. SURVEILLANCE OF PATIENTS AND HEALTH CARE PROVIDERS PATIENT SURVEILLANCE Prescription tracking systems have a legitimate role in preventing diversion of controlled medications but some countries have instituted much more invasive surveillance of patients. In Georgia, for example, patients are required to visit police stations to fill their opioid prescriptions. Intrusive surveillance deters legitimate use of controlled medicines and may violate privacy rights. SURVEILLANCE AND LEGAL SANCTION OF HEALTHCARE WORKERS Healthcare institutions that handle controlled substances are required to keep records so that the authorities can monitor their use. However, some countries have created invasive systems of control that may deter or stigmatize prescribing of controlled medicines or violate privacy rights. For example, in Ukraine, staff who handle opioids are subject to blood tests, and empty morphine ampoules must be collected and counted. PROVEN TREATMENT ILLEGAL UNODC, UNAIDS and WHO agree that opioid substitution therapy (OST) using methadone or buprenorphine is one of the most effective treatments for opioid dependence, and critical to HIV prevention and facilitating antiretroviral therapy among people who inject drugs. 8 Yet, methadone for OST is illegal in Russia, Malaysia, the Philippines and Sri Lanka; use of buprenorphine for OST is illegal in Burma; and both are illegal in Bangladesh, Bhutan, Cambodia, Japan and Singapore. In many other countries, including Pakistan, Kazakhstan, Egypt, Argentina and Brazil, large numbers of people inject opioids, but no OST is available. 9 INNOVATIVE REGULATION PROMOTING SAFE ACCESS TO CONTROLLED MEDICINES COMPREHENSIVE REGULATORY REFORM Several countries, including Vietnam, Colombia and Romania, have undertaken comprehensive reviews of their drug control regulations, as recommended by the INCB, to ensure that they do not unnecessarily impede access to controlled medicines. As a result, all three countries increased the amount of time that oral morphine can be prescribed for using one prescription to 30 days, from previous limits between 3 and 10 days. Romania also changed its regulations to ensure that all doctors could prescribe opioids and that all patients in pain could receive them, regardless of their underlying disease. 10 Vietnam expanded the types of health facilities that are authorized to prescribe and dispense opioids, and mandated that district hospitals stock opioid medicines if no pharmacy in a district does. NURSE PRESCRIBING Uganda, the United Kingdom and most states in the United States allow nurses to prescribe controlled medicines in certain circumstances. In some cases, pharmacists, clinical officers or physician’s assistants may also be licensed to prescribe controlled medicines. For example, in 2008 Vietnam amended its law to allow assistant doctors to prescribe morphine when no doctor is available. 11 Nurse prescribing has the most potential to improve access to controlled medicines in resource-limited settings where there are not enough doctors. The INCB has commended Uganda for its efforts to increase access to controlled medicines. 12 EMERGENCY PRESCRIBING Lithuania and the United Kingdom allow pharmacists and nurses to prescribe controlled medicines when a patient is in severe pain and no doctor is available. They also allow doctors to authorize an emergency prescription by telephone or fax, as do many other European countries. 13 Photo: Palliative care nurses and volunteers check up on a 67-year-old woman, who is paralyzed and taking morphine for pain in south Kerala. © 2009 Brent Foster

Transcript of Proven treat - HRW

Page 1: Proven treat - HRW

Drug Control anD aCCess to ControlleD MeDiCines: a global view

aCCess to ControlleD MeDiCines anD the un Drug ConventionsThe 1961 Single Convention on Narcotic Drugs obliges states to make “adequate provision… to ensure the availability of narcotic drugs” which continue to be “indispensable for the relief of pain and suffering.” The international Narcotics Control board (iNCb) has stated that the Single Convention “establishes a dual drug control obligation: to ensure adequate availability of narcotic drugs for medical and scientific purposes, while at the same time preventing the illicit production of, and trafficking in and use of such drugs.” Yet, the President of the iNCb observed in July 2009 that access to controlled medicines is “virtually non-existent in over 150 countries.” ensuring the availability of essential medicines like morphine, methadone and buprenorphine is a core obligation of governments under the right to the highest attainable standard of health. Drug control regulations that restrict the adequate availability of these medications violate that right. Denial of strong opioids to patients in severe pain can also constitute cruel, inhuman or degrading treatment.

regulatory barriers to MeDiCal aCCess to ControlleD Drugsaccess to controlled medicines must be regulated to prevent their misuse. The 1961 Single Convention establishes three basic requirements for such regulations:

Controlled medicines may be dispensed only pursuant •to a prescription;a license must be required to manufacture, trade or •distribute them, and appropriate records must be kept.• 1

Yet, many countries have enacted regulations that go well beyond what is required by the Single Convention and that impede availability of controlled medications. iNCb has repeatedly called on countries to review their drug control regulations to assess whether they unnecessarily impede access to controlled medicines.2

PresCriPtion ProCeDuresSPeCial PreSCriPTioN formS•many countries, like Turkey, require use of a special prescription for controlled medicines. wHo has observed that special multiple-copy prescription requirements “typically reduce prescribing of covered drugs by 50 percent or more.” The requirement to use special prescription forms can be particularly burdensome if doctors have to apply to receive the

forms, as in morocco and germany, or have to pay for them, as in the Philippines, Denmark, albania and estonia. Problems accessing enough special prescription forms have been reported in Turkey, el Salvador and Ukraine.

PreSCriPTioN limiTaTioNS•many countries, like morocco, limit the number of days a prescription for controlled medicines can cover. wHo recommends “decisions concerning…the amount of the prescription and the duration of therapy are best made by medical professionals on the basis of the individual need of the patient, not by regulation.”3 extreme time limits include Ukraine (1 day), belarus (3 days), greece, lithuania and russia (5 days). in many other countries, an opioid prescription may be valid for as many as 90 days or there is no limitation at all.4

rigHT To PreSCribe limiTeD To CerTaiN SPeCialiSTS•like montenegro, some countries limit the right to prescribe opioids to doctors practicing in certain specialties, commonly oncology, pain management or anesthesiology. Such restrictions significantly limit patients’ access to opioid medicines. The wHo recommends that “physicians, nurses and pharmacists should be legally empowered to prescribe, dispense and administer opioids to patients in accordance with local needs.”5 Countries with similar restrictions include, among others, egypt and Ukraine.6

liCensing requireMentsSPeCial liCeNSeS for DoCTorS•in many countries, like greece, doctors need a special license or registration to prescribe controlled medicines. while in some countries the process for obtaining a license is simple, in others obtaining it requires considerable paperwork or even invasive screening of the doctor. for example, the Philippines requires doctors applying for a license to submit to blood tests. as a result of excessively complex licensing procedures in some countries, including morocco and the Philippines, very few doctors obtain them.7

liCeNSeS for PHarmaCieS, HoSPiTalS aND •HoSPiCeS The UN drug conventions require that states create a system to license healthcare institutions that handle opioid medications. Some countries arbitrarily exclude certain healthcare facilities from eligibility for a license

*Except where otherwise noted, all information is from Human Rights Watch interviews or correspondence with healthcare professionals in the countries mentioned. These examples are illustrative of regulations that promote or impede access to controlled medicines and do not fully reflect the regulatory environment in the countries mentioned. These examples are not intended to suggest that practices in the countries mentioned are better or worse than those in countries not mentioned. Non-regulatory barriers also contribute to the unavailability of controlled medicines, particularly inadequate training for healthcare workers in their use. additional sources of information on reverse: Jordan: Jan Stjernswärd et al., “Jordan Palliative Care initiative: a wHo Demonstration Project”, Journal of Pain and Symptom management, vol. 33 no. 5, may 2007, 631; rwanda: international Narcotics Control board, Narcotic Drugs: estimated world requirements for 2009 – Statistics for 2007, e/f/S.09.Xi.02 (New York: United Nations, 2009), p. 241; K. m. foley, “Pain Syndromes in Patients with Cancer,” in K. m. foley, J. J. bonica and v. ventafridda, eds., advances in Pain research and Therapy, (New York: raven Press, 1979), 981_994; UNaiDS, “rwanda: Country Situation”, July 2008, http://data.unaids.org/pub/factSheet/2008/sa08_rwa_en.pdf (accessed february 9, 2010); Singapore: Central Narcotics bureau, annual bulletin, 2007.

1 Single Convention on Narcotic Drugs, 1961, adopted

march 30, 1961, 520 U.N.T.S. 151, entered into force December 13, 1964, preamble.

2 international Narcotics Control board, “availability of opiates

for medical Needs: report of the international Narcotics Control board for 1995,” http://www.incb.org/pdf/e/ar/1995/suppl1en.pdf (accessed february 10, 2010), p. 1.

3 UN economic and Social Council, “Statement

by Professor Sevil atasoy, President of the international Narcotics Control board,” July 30, 2009, http://www.incb.org/documents/President_statements_09/2009_eCoSoC_Substantive_Session_published.pdf (accessed february 10, 2010), p. 2.

4 UN Committee on economic, Social

and Cultural rights, “Substantive issues arising in the implementation of the international Covenant on economic, Social and Cultural rights,” general Comment No. 14, The right to the Highest attainable Standard of Health, e/C.12/2000/4 (2000), http://www.unhchr.ch/tbs/doc.nsf/(symbol)/e.C.12.2000.4.en (accessed february 9, 2010), para. 43. 5

Human rights Council, report of the Special rapporteur on Torture and other Cruel, inhuman or Degrading Treatment or Punishment, manfred Nowak, “Promotion and Protection of all Human rights, Civil Political, economic, Social and Cultural rights, including the right to Development,” a/HrC/10/44, January 14, 2009, para. 72.

6 international

Narcotics Control board, report of the international Narcotics Control board for 2008, e.09.Xi.1 (New York: United Nations, 2009), p. 118. 7 wHo, Cancer pain relief: with a guide to opioid availability, 2nd ed.,

(geneva: wHo, 1996). 8

N.i. Cherney et.al, “formulary availability and regulatory barriers to accessibility of opioids for cancer pain in europe: a report from the eSmo/eaPC opioid Policy initiative”, annals of oncology, forthcoming, february 2010.

9 evan anderson et al., “Closing the gap:

Case Studies of opioid access reform in China, india, romania & vietnam” (Centers for law and Public Health: a Collaborative at the Johns Hopkins and georgetown Universities, 2008).

10 wHo, UNoDC, UNaiDS,

Position Paper: Substitution maintenance therapy in the management of opioid dependence and Hiv/aiDS prevention, (geneva: world Health organization, 2004).

11 Catherine Cook and Natalya Kanaef, global State

of Harm reduction 2008: mapping the response to drug-related Hiv and Hepatitis C epidemics (london: international Harm reduction association, 2008).

12 Daniela mosoiu, et al., “romania: Changing the regulatory

environment,” Journal of Pain and Symptom management, vol. 33 no. 5, may 2007, 610.

13 international Narcotics Control board, report of

the international Narcotics Control board for 2004, e.05.Xi.3 (New York: United Nations, 2005), para. 196.

or have unnecessarily burdensome licensing procedures that deter pharmacies and medical institutions from stocking controlled medicines, and divert healthcare workers’ time from providing medical care.

The licensing system in most of india’s states, where healthcare providers must obtain five different licenses from several government agencies, is a prime example. To its credit, the indian government has recommended partial reform to improve patient access to morphine. Today, 14 states have adopted a new, simple system for morphine that involves obtaining one license from one government agency. in China, hospitals are categorized according to their size, and only larger hospitals are authorized to handle opioids. as a result, people living outside of large cities have to travel much further to obtain opioid medicines than they would if they were available in all hospitals.

surveillanCe of Patients anD health Care ProviDers

PaTieNT SUrveillaNCe •Prescription tracking systems have a legitimate role in preventing diversion of controlled medications but some countries have instituted much more invasive surveillance of patients. in georgia, for example, patients are required to visit police stations to fill their opioid prescriptions. intrusive surveillance deters legitimate use of controlled medicines and may violate privacy rights.

SUrveillaNCe aND legal SaNCTioN of HealTHCare •worKerS Healthcare institutions that handle controlled substances are required to keep records so that the authorities can monitor their use. However, some countries have created invasive systems of control that may deter or stigmatize prescribing of controlled medicines or violate privacy rights. for example, in Ukraine, staff who handle opioids are subject to blood tests, and empty morphine ampoules must be collected and counted.

Proven treatMent illegalUNoDC, UNaiDS and wHo agree that opioid substitution therapy (oST) using methadone or buprenorphine is one of the most effective treatments for opioid dependence, and critical to Hiv prevention and facilitating antiretroviral therapy among people who inject drugs.8 Yet, methadone

for oST is illegal in russia, malaysia, the Philippines and Sri lanka; use of buprenorphine for oST is illegal in burma; and both are illegal in bangladesh, bhutan, Cambodia, Japan and Singapore. in many other countries, including Pakistan, Kazakhstan, egypt, argentina and brazil, large numbers of people inject opioids, but no oST is available.9

innovative regulation ProMoting safe aCCess to ControlleD MeDiCinesComPreHeNSive regUlaTorY reformSeveral countries, including vietnam, Colombia and romania, have undertaken comprehensive reviews of their drug control regulations, as recommended by the iNCb, to ensure that they do not unnecessarily impede access to controlled medicines. as a result, all three countries increased the amount of time that oral morphine can be prescribed for using one prescription to 30 days, from previous limits between 3 and 10 days. romania also changed its regulations to ensure that all doctors could prescribe opioids and that all patients in pain could receive them, regardless of their underlying disease.10 vietnam expanded the types of health facilities that are authorized to prescribe and dispense opioids, and mandated that district hospitals stock opioid medicines if no pharmacy in a district does.

NUrSe PreSCribiNgUganda, the United Kingdom and most states in the United States allow nurses to prescribe controlled medicines in certain circumstances. in some cases, pharmacists, clinical officers or physician’s assistants may also be licensed to prescribe controlled medicines. for example, in 2008 vietnam amended its law to allow assistant doctors to prescribe morphine when no doctor is available.11 Nurse prescribing has the most potential to improve access to controlled medicines in resource-limited settings where there are not enough doctors. The iNCb has commended Uganda for its efforts to increase access to controlled medicines.12

emergeNCY PreSCribiNglithuania and the United Kingdom allow pharmacists and nurses to prescribe controlled medicines when a patient is in severe pain and no doctor is available. They also allow doctors to authorize an emergency prescription by telephone or fax, as do many other european countries.13

Photo: Palliative care nurses and volunteers check up on a 67-year-old woman, who is paralyzed and taking morphine for pain in south Kerala. © 2009 Brent Foster

Page 2: Proven treat - HRW

syr

ia o

ut-p

atie

nts

mus

t vi

sit t

he

min

istr

y of

Hea

lth

to o

bta

in m

orp

hin

eo

ut-p

atie

nts

can

only

re

ceiv

e or

al m

orph

ine

afte

r obt

aini

ng p

erm

issi

on

from

the

min

istr

y of

H

ealt

h in

Dam

ascu

s. T

his

unne

cess

arily

com

plic

ates

ac

cess

to th

ese

esse

ntia

l m

edic

atio

ns, e

spec

ially

fo

r tho

se w

ho li

ve o

utsi

de

the

capi

tal c

ity.

tan

zan

ia m

orp

hin

e no

t av

aila

ble

in p

harm

acie

sif

a h

osp

ital

wan

ts to

of

fer o

ral m

orp

hin

e to

it

s pa

tien

ts, a

qua

lified

p

harm

acis

t has

to c

olle

ct

it fr

om th

e ca

pit

al c

ity,

a

trip

that

can

take

up

to

thre

e da

ys.

as

a re

sult

, ve

ry fe

w h

osp

ital

s ha

ve

oral

mor

ph

ine,

leav

ing

mos

t pat

ient

s w

ith

sev

ere

pain

to s

uffe

r.

Dr

ug

Co

ntr

ol

an

D a

CCes

s to

Co

ntr

oll

eD

MeD

iCin

es:

Sele

CTeD

eX

am

PleS

ro

Ma

nia

com

pre

hen

sive

re

gula

tory

refo

rmN

ew d

rug

regu

lati

ons

enac

ted

in 2

006

sign

ifica

ntly

imp

rove

d ac

cess

ibili

ty o

f con

trol

led

med

icat

ions

, aut

hor

izin

g al

l doc

tors

to p

resc

rib

e op

ioid

s an

d a

llow

ing

pati

ents

in s

ever

e pa

in to

re

ceiv

e op

ioid

s re

gard

less

of

the

und

erly

ing

dis

ease

.

lith

ua

nia

em

erge

ncy

pre

scri

bin

gN

urse

s an

d ph

arm

acis

ts

may

pre

scri

be o

pioi

ds in

em

erge

ncie

s, m

eani

ng

pati

ents

no

long

er h

ave

to

suff

er a

goni

zing

pai

n if

no

doct

or is

ava

ilabl

e.

ru

ss

ia e

ffec

tive

tr

eatm

ent i

llega

lo

pio

id s

ubst

itut

ion

ther

apy

wit

h m

etha

don

e or

bup

reno

rph

ine

is

illeg

al, l

eavi

ng h

und

reds

of

thou

sand

s of

rus

sian

s w

ith

out e

ffec

tive

tr

eatm

ent f

or d

rug

dep

end

ence

and

at h

igh

risk

of H

iv in

fect

ion.

inD

ia m

ultip

le li

cens

es

requ

ired

to p

rocu

re o

pioi

dsin

man

y st

ates

, hos

pit

als

req

uire

as

man

y as

five

di

ffere

nt li

cens

es to

pro

cure

an

d s

tock

mor

ph

ine

and

the

pro

cure

men

t pro

cess

ca

n ta

ke m

onth

s. a

s a

resu

lt, m

any

hos

pit

als

sim

ply

do

not s

tock

the

med

icat

ion,

ab

and

onin

g co

untl

ess

pati

ents

to

excr

ucia

ting

pai

n.

Ch

ina

man

y h

osp

ital

s ar

e b

arre

d

from

pre

scri

bin

g op

ioid

so

nly

hos

pit

als

wit

h a

ce

rtai

n ra

nk, w

hic

h is

b

ased

on

thei

r siz

e, a

re

auth

oriz

ed to

pre

scri

be

opio

id m

edic

atio

ns. a

s a

resu

lt, h

osp

ital

s in

man

y ci

ties

and

tow

ns c

anno

t d

isp

ense

op

ioid

s an

d p

eopl

e m

ay h

ave

to tr

avel

lo

ng d

ista

nces

in o

rder

to

be

able

to o

bta

in th

em.

Mex

iCo

few

hos

pit

als

and

pha

rmac

ies

stoc

k m

orp

hin

em

exic

o Ci

ty h

as a

po

pula

tion

of 1

8 m

illio

n pe

ople

, yet

onl

y ni

ne o

f its

ho

spita

ls o

r pha

rmac

ies

stoc

k m

orph

ine,

ap

pare

ntly

bec

ause

of

burd

enso

me

regu

lato

ry

requ

irem

ents

. Th

is

mak

es p

ain

trea

tmen

t in

acce

ssib

le to

mos

t of

the

city

’s in

habi

tant

s.

uk

ra

ine

unn

eces

sari

ly

com

plex

pre

scri

pti

on

pro

ced

ures

Th

ree

doc

tors

mus

t si

gn e

ach

mor

ph

ine

pre

scri

pti

on.

This

cu

mb

erso

me

pro

cess

m

akes

man

y d

octo

rs

relu

ctan

t to

pre

scri

be

the

med

icat

ion.

geo

rg

ia p

atie

nt

surv

eilla

nce

mor

ph

ine

is d

isp

ense

d to

ou

t-p

atie

nts

from

sp

ecia

l ph

arm

acie

s in

dis

tric

t p

olic

e-st

atio

ns, s

tigm

atiz

ing

its

legi

tim

ate

med

ical

us

e an

d c

omp

rom

isin

g p

atie

nts’

pri

vacy

.

gr

eeCe

per

mit

s re

qui

red

for d

octo

rs a

nd p

atie

nts

Doc

tors

nee

d a

sp

ecia

l p

erm

it to

pre

scri

be

opio

id

med

icin

es a

nd p

atie

nts

need

one

to re

ceiv

e th

em.

bot

h re

qui

rem

ents

det

er

the

legi

tim

ate

med

ical

us

e of

op

ioid

s.

Mo

nte

neg

ro

man

y sp

ecia

lists

can

not

pre

scri

be

opio

ids

onc

olog

ists

may

pre

scri

be

opio

id m

edic

ines

but

m

any

othe

r spe

cial

ists

ca

nnot

, sev

erel

y lim

itin

g

acce

ss to

opi

oid

med

icin

es

for p

atie

nts

with

pai

n fr

om

caus

es o

ther

than

can

cer.

Colo

Mb

ia i

ncre

ase

in ti

me

limit

for o

pio

id

pre

scri

pti

ons

in 2

00

6, n

ew re

gula

tion

s in

crea

sed

the

leng

th

of ti

me

for w

hic

h o

ral

mor

ph

ine

can

be

pre

scri

bed

usi

ng o

ne

pre

scri

pti

on fr

om 1

0 to

3

0 d

ays.

Jor

Da

n r

efor

ms

to a

llow

al

l doc

tors

to p

resc

rib

e op

ioid

sS

ince

20

04

, all

doc

tors

ca

n p

resc

rib

e m

orp

hin

e.

Prev

ious

ly, o

nly

onco

logi

sts

coul

d, m

akin

g tr

eatm

ent

inac

cess

ible

to p

eopl

e w

ith

sev

ere

pain

from

ca

uses

oth

er th

an c

ance

r.

viet

na

M a

ll d

istr

icts

m

ust h

ave

stro

ng o

pio

ids

Sin

ce 2

008,

regu

lati

ons

requ

ire

dist

rict

hos

pita

ls

to s

tock

opi

oid

med

icin

es

if no

pha

rmac

y in

a

dist

rict

doe

s, c

onsi

dera

bly

impr

ovin

g ac

cess

ibili

ty.

sin

ga

Por

e e

ffec

tive

tr

eatm

ent i

llega

lb

upre

norp

hin

e is

a

ban

ned

sub

stan

ce,

leav

ing

thou

sand

s of

p

eopl

e w

ith

out e

ffec

tive

tr

eatm

ent f

or d

rug

dep

end

ence

and

at h

igh

risk

of H

iv in

fect

ion.

Mo

ro

CCo

pre

scri

pti

on

limit

atio

nsPa

tien

ts c

an o

nly

get

one

wee

k’s

supp

ly

of m

orp

hin

e p

er

pre

scri

pti

on, m

eani

ng

that

they

mus

t pic

k up

a

new

pre

scri

pti

on e

very

w

eek.

for

pat

ient

s w

ho

are

term

inal

ly il

l or l

ive

far

from

thei

r doc

tor t

his

is

very

dif

ficul

t.

tur

key

sp

ecia

l op

ioid

p

resc

rip

tion

form

sPr

escr

ipti

ons

for s

tron

g op

ioid

s m

ust b

e m

ade

on

a sp

ecia

l pre

scrip

tion

form

. Pr

ocur

ing

thes

e fo

rms

is

tim

e-co

nsum

ing;

man

y d

octo

rs d

o no

t kee

p a

su

pply

of t

hem

and

are

not

ab

le to

pre

scri

be

opio

ids

to p

atie

nts

in p

ain.

exa

MPl

es o

f g

oo

D r

egu

lati

on

exa

MPl

es o

f Po

or

reg

ula

tio

n

ug

an

Da

nur

se p

resc

ribin

gS

ince

20

04

, sp

ecia

lly

trai

ned

nur

ses

and

clin

ical

offi

cers

are

au

thor

ized

to p

resc

rib

e m

orp

hin

e, s

igni

fican

tly

incr

easi

ng it

s ac

cess

ibili

ty

in a

cou

ntry

wit

h a

sev

ere

shor

tage

of d

octo

rs.

rw

an

Da

alm

ost n

o op

ioid

s av

aila

ble

UN

dru

g co

nven

tions

re

quire

sta

tes

to e

nsur

e ad

equa

te ‘a

vaila

bilit

y of

na

rcot

ic d

rugs

for [

med

ical

] pu

rpos

es.’

Yet,

bet

wee

n 20

03 a

nd 2

007,

rw

anda

used

an

amou

nt o

f m

orph

ine

suffi

cien

t to

trea

t onl

y 33

0 of

the

mor

e th

an 4

0,00

0 pa

tient

s w

ho d

ied

of c

ance

r dur

ing

that

per

iod,

80

perc

ent o

f w

hom

are

like

ly to

hav

e su

ffere

d si

gnifi

cant

pai

n.